WORK Medical Technology Group LTD financial data

Symbol
WOK on Nasdaq
Location
Building 23, No. 2 Tonghuinan Rd., Xiaoshan District, Hangzhou, China
State of incorporation
China
Fiscal year end
September 30
Former names
WORK Medical Technology LTD (to 6/23/2022)
Latest financial report
20-F - Q3 2024 - Feb 14, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.6M shares
Common Stock, Shares, Outstanding 14.6M shares +16.7%
Common Stock, Value, Issued 7.3K USD +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.56M USD +311%
Accounts Receivable, after Allowance for Credit Loss, Current 1.65M USD -50.5%
Inventory, Net 3.18M USD -31.1%
Assets, Current 20.8M USD -5.98%
Deferred Income Tax Assets, Net 113K USD +68.9%
Property, Plant and Equipment, Net 11.4M USD +71.6%
Intangible Assets, Net (Excluding Goodwill) 1.04M USD +4.57%
Assets 36.3M USD +21%
Accounts Payable, Current 1.5M USD -62.2%
Employee-related Liabilities, Current 231K USD -63.1%
Contract with Customer, Liability, Current 625K USD -19.4%
Liabilities, Current 20.2M USD +6.65%
Liabilities 20.2M USD +6.36%
Accumulated Other Comprehensive Income (Loss), Net of Tax -408K USD +39.7%
Retained Earnings (Accumulated Deficit) 6.08M USD -36.6%
Stockholders' Equity Attributable to Parent 13.2M USD +33.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.1M USD +46.3%
Liabilities and Equity 36.3M USD +21%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 14.6M shares +16.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.56M USD +301%
Deferred Tax Assets, Valuation Allowance 78.2K USD +30.6%
Deferred Tax Assets, Gross 329K USD -48%
Property, Plant and Equipment, Gross 17.6M USD -0.72%
Deferred Tax Assets, Operating Loss Carryforwards 78.2K USD +49.4%
Deferred Tax Assets, Net of Valuation Allowance 251K USD -56.2%